Online seminars as an information source for direct-to-consumer stem cell therapy.
Regen Med
; 17(2): 81-90, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1581477
ABSTRACT
Aim:
To attend stem cell (SC) seminars hosted by US-based direct-to-consumer SC businesses either in person or via online 'webinars' to determine accuracy and regulatory oversight of the advertised SC therapies.Methods:
The therapeutic claims, costs, risks, scientific evidence in support of a therapy and any regulatory oversight were collated using pre-established checklists. Participation consisted of one live attendance of a seminar, and following COVID-19 restrictions, review of seven recorded presentations available on the internet from SC businesses. Results &conclusion:
None of the SC therapies advertised by direct-to-consumer clinics reviewed were supported by proper clinical evidence nor substantiated by peer reviewed literature.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Regen Med
Year:
2022
Document Type:
Article
Affiliation country:
Rme-2021-0070
Similar
MEDLINE
...
LILACS
LIS